• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

• D
• Davletov, Bazbek
  Neuresta
• (T1030-01-07) Evaluation of Formation of SpyTag Form of Botulinum Toxin A (BoNT/A) by Electrochemiluminescence Sandwich Immunoassay
  Bazbek Davletov
  Favorite
• DeBrabandere, Veronique
  Sanofi
• (M1330-01-06) In Vitro Assessment of Physicochemical Properties of Biologics for the Early Identification of Pharmacokinetic Liabilities in a Developability Workflow
  Veronique DeBrabandere
  Favorite
• DeGroot, Anne
  EpiVax Inc.
• (M1030-01-04) Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
  Anne DeGroot
  Favorite
• (M1130-01-05) Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
  Anne DeGroot
  Favorite
• DeLaney, Kellen
  Waters Corporation
• (M1030-01-02) Identification and Characterization of Impurities in Lipid Nanoparticle Components Using TOF-MS with Predictive In Silico Fragmentation and Automated Data Processing
  Kellen DeLaney
  Favorite
• Dellatore, Shara
  Merck & Co., Inc.
• (T1130-01-04) Validation of an Anti-drug Antibody (ADA) Assay Using the Mitra VAMS Microsampling Technology in Support of a Phase I Clinical Study
  Shara Dellatore
  Favorite
• Di, Jiaxing
  Purdue University
• (M1130-01-02) Multiscale Pharmacokinetic Modeling and Simulation of Local and Systemic Exposure of Intramuscularly Injected LNPs
  Jiaxing Di
  Favorite
• D'Souza, Martin
  Mercer University
• (M1130-01-01) An Adjuvanted Microparticulate Microneedle-Based Gonorrhea Vaccine Induced a Robust Immune Response in Mice
  Martin D'Souza
  Favorite
• Dube, Namita
  Rensselaer Polytechnic Institute
• (T1030-01-09) Virtual Screening of SARS Cov 2 Papain Like Protease Inhibitors
  Namita Dube
  Favorite
• Dutt, Muskaan
  Altasciences
• (M1330-01-05) Application of Mitra Microsampling for the Quantitative Bioanalysis of Antisense Oligonucleotides
  Muskaan Dutt
  Favorite